David Engelmann
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 6
- DNA Repair Mechanisms 3
- RNA modifications and cancer 3
- Histone Deacetylase Inhibitors Research 2
- Oncology 11
- Cancer-related Molecular Pathways 8
- Cancer Cells and Metastasis 3
- Co-authors
- Brigitte M. Pützer (21 shared papers)Vijay Alla (6 shared papers)Alf Spitschak (9 shared papers)Claudia Meier (4 shared papers)Ulf Schmitz (4 shared papers)Olaf Wolkenhauer (6 shared papers)Bhavani S. Kowtharapu (3 shared papers)Stephan Emmrich (2 shared papers)
- Journals
- Cancer Research (3 papers)Theranostics (2 papers)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)Molecular Cancer (1 paper)Drug Resistance Updates (1 paper)
- Partner nations
- GermanySouth AfricaSwitzerland
In The Last Decade
David Engelmann
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 320
- Oncology 367
- Molecular Biology 714
- Biotechnology 51
- Immunology and Allergy 24
Countries citing papers authored by David Engelmann
This map shows the geographic impact of David Engelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Engelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Engelmann more than expected).
Fields of papers citing papers by David Engelmann
This network shows the impact of papers produced by David Engelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Engelmann. The network helps show where David Engelmann may publish in the future.
Co-authors
The 25 scholars most cited alongside David Engelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 126 | |
| 2 | 2009 | 105 | |
| 3 | 2012 | 82 | |
| 4 | 2013 | 81 | |
| 5 | 2012 | 76 | |
| 6 | 2020 | 72 | |
| 7 | 2017 | 69 | |
| 8 | 2013 | 58 | |
| 9 | 2010 | 54 | |
| 10 | 2017 | 50 | |
| 11 | 2013 | 47 | |
| 12 | 2014 | 45 | |
| 13 | 2015 | 32 | |
| 14 | 2014 | 30 | |
| 15 | 2006 | 27 | |
| 16 | 2016 | 26 | |
| 17 | 2013 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 2009 | 20 | |
| 20 | 2008 | 18 |
About David Engelmann
David Engelmann is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (6 papers), DNA Repair Mechanisms (3 papers), Cancer Cells and Metastasis (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Cancer Genomics and Diagnostics (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (320 citations), Oncology (367 citations), Molecular Biology (714 citations), Biotechnology (51 citations) and Immunology and Allergy (24 citations). David Engelmann has collaborated with scholars based in Germany, South Africa and Switzerland. Frequent co-authors include Brigitte M. Pützer, Vijay Alla, Alf Spitschak, Claudia Meier, Ulf Schmitz, Olaf Wolkenhauer, Bhavani S. Kowtharapu, Stephan Emmrich, Jens Pahnke and Stephan Marquardt. Their work appears in journals such as Cancer Research, Theranostics, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Molecular Cancer and Drug Resistance Updates.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.